Skip to main content
. 2019 Oct 21;20:224. doi: 10.1186/s12931-019-1185-9

Table 2.

The status of patients with MAC (n = 61)

Type of bacteria M.avium 47
M.intracellulare 8
M.avium + M.intracellulare 2
M.avium + M.chelonae 1
M.avium + M.abscessus 1
M.avium + M.scrofulaceum 1
M.intracellulare + M.fortuitum 1
HRCT findings NB type/NB + FC type/FC type 47/5/7
MAC-Ab (antibody titer) positive/negative 43 (0.7–87.6) / 18 (< 0.6)
Treatment untreated/undergoing treatment/post-treatment 33/21/7
Immunosuppressive drug positive/negative 12/49
IGRA (QFT or T-SPOT) positive/negative/undeterminable or unknown 4/51/6

Data are presented as the number of patients

Abbreviations: HRCT high-resolution computed tomography, NB type nodular bronchiectatic type, FC type fibrocavitary type, IGRA interferon-gamma releasing assay